| Title | When to start antiretroviral therapy in resource-limited settings. |
| Publication Type | Journal Article |
| Year of Publication | 2009 |
| Authors | Walensky, Rochelle P., Lindsey L. Wolf, Robin Wood, Mariam O. Fofana, Kenneth A. Freedberg, Neil A. Martinson, David A. Paltiel, Xavier Anglaret, Milton C. Weinstein, and Elena Losina |
| Corporate Authors | CEPAC(Cost-Effectiveness of Preventing AIDS Complications)-International Investigators |
| Journal | Annals of internal medicine |
| Volume | 151 |
| Issue | 3 |
| Pagination | 157-66 |
| Date Published | 2009 Aug 4 |
| ISSN | 1539-3704 |
| Keywords | Adult, AIDS-Related Opportunistic Infections, Anti-HIV Agents, Anti-Infective Agents, CD4 Lymphocyte Count, Cohort Studies, Computer Simulation, Cost-Benefit Analysis, Decision Trees, Disease Progression, Drug Administration Schedule, Health Care Costs, HIV Infections, Humans, Life Expectancy, Sensitivity and Specificity, South Africa, Trimethoprim-Sulfamethoxazole Combination |
| Abstract | The results of international clinical trials that are assessing when to initiate antiretroviral therapy (ART) will not be available for several years. |
| DOI | 10.1111/j.1524-4733.2010.00763.x |
| Alternate Journal | Ann. Intern. Med. |
